217 related articles for article (PubMed ID: 32793603)
1. Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches.
Erbani J; Tay J; Barbier V; Levesque JP; Winkler IG
Front Cell Dev Biol; 2020; 8():668. PubMed ID: 32793603
[TBL] [Abstract][Full Text] [Related]
2. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.
Barbier V; Erbani J; Fiveash C; Davies JM; Tay J; Tallack MR; Lowe J; Magnani JL; Pattabiraman DR; Perkins AC; Lisle J; Rasko JEJ; Levesque JP; Winkler IG
Nat Commun; 2020 Apr; 11(1):2042. PubMed ID: 32341362
[TBL] [Abstract][Full Text] [Related]
3. Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1.
Winkler IG; Snapp KR; Simmons PJ; Lévesque JP
Blood; 2004 Mar; 103(5):1685-92. PubMed ID: 14592840
[TBL] [Abstract][Full Text] [Related]
4. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
5. Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias.
Kappelmayer J; Kiss A; Karászi E; Veszprémi A; Jakó J; Kiss C
Br J Haematol; 2001 Dec; 115(4):903-9. PubMed ID: 11843824
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells.
Zhai Y; Zhang J; Wang H; Lu W; Liu S; Yu Y; Weng W; Ding Z; Zhu Q; Shi J
J Exp Clin Cancer Res; 2016 Sep; 35(1):147. PubMed ID: 27643489
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43.
Spertini C; Baïsse B; Bellone M; Gikic M; Smirnova T; Spertini O
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31461905
[TBL] [Abstract][Full Text] [Related]
8. Shear stress-mediated adhesion of acute myeloid leukemia and KG-1 cells to endothelial cells involves functional P-selectin.
Bistrian R; Dorn A; Möbest DC; Rüster B; Ludwig R; Scheele J; Seifried E; Martin H; Henschler R
Stem Cells Dev; 2009 Oct; 18(8):1235-42. PubMed ID: 19105599
[TBL] [Abstract][Full Text] [Related]
9. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
[TBL] [Abstract][Full Text] [Related]
10. Relationship of P-selectin glycoprotein ligand-1 to prognosis in patients with multiple myeloma.
Atalay F; Ateşoğlu EB; Yıldız S; Firatlı-Tuglular T; Karakuş S; Bayık M
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):164-70. PubMed ID: 25445472
[TBL] [Abstract][Full Text] [Related]
11. Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.
Enjeti AK; Fogler WE; Smith TAG; Lincz LF; Bond DR; Magnani JL
Br J Haematol; 2024 Jun; 204(6):2264-2274. PubMed ID: 38659295
[TBL] [Abstract][Full Text] [Related]
12. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
13. RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice.
Morita K; Tokushige C; Maeda S; Kiyose H; Noura M; Iwai A; Yamada M; Kashiwazaki G; Taniguchi J; Bando T; Hirata M; Kataoka TR; Nakahata T; Adachi S; Sugiyama H; Kamikubo Y
Blood Adv; 2018 Mar; 2(5):509-515. PubMed ID: 29500219
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system.
Alhattab DM; Isaioglou I; Alshehri S; Khan ZN; Susapto HH; Li Y; Marghani Y; Alghuneim AA; Díaz-Rúa R; Abdelrahman S; Al-Bihani S; Ahmed F; Felimban RI; Alkhatabi H; Alserihi R; Abedalthagafi M; AlFadel A; Awidi A; Chaudhary AG; Merzaban J; Hauser CAE
Biomater Res; 2023 Nov; 27(1):111. PubMed ID: 37932837
[TBL] [Abstract][Full Text] [Related]
15. Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells.
Gul-Uludağ H; Valencia-Serna J; Kucharski C; Marquez-Curtis LA; Jiang X; Larratt L; Janowska-Wieczorek A; Uludağ H
Leuk Res; 2014 Nov; 38(11):1299-308. PubMed ID: 25262448
[TBL] [Abstract][Full Text] [Related]
16. The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia.
Pimenta DB; Varela VA; Datoguia TS; Caraciolo VB; Lopes GH; Pereira WO
Front Cell Dev Biol; 2021; 9():764698. PubMed ID: 34869355
[TBL] [Abstract][Full Text] [Related]
17. Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow.
Sanz-Ortega L; Andersson A; Carlsten M
Leukemia; 2024 Mar; 38(3):579-589. PubMed ID: 38182818
[TBL] [Abstract][Full Text] [Related]
18. An Analysis of Trafficking Receptors Shows that CD44 and P-Selectin Glycoprotein Ligand-1 Collectively Control the Migration of Activated Human T-Cells.
Ali AJ; Abuelela AF; Merzaban JS
Front Immunol; 2017; 8():492. PubMed ID: 28515724
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
[TBL] [Abstract][Full Text] [Related]
20. Targeting the microenvironment in acute myeloid leukemia.
Rashidi A; Uy GL
Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
